爱尔眼科收盘下跌1.91%，滚动市盈率32.39倍，总市值1200.39亿元

Group 1 - The core viewpoint of the article highlights the financial performance and market position of Aier Eye Hospital Group, indicating a decline in stock price and its relative valuation within the medical services industry [1] - As of May 15, Aier Eye Hospital's stock closed at 12.87 yuan, down 1.91%, with a rolling PE ratio of 32.39 times and a total market capitalization of 1200.39 billion yuan [1] - The average PE ratio for the medical services industry is 37.79 times, with a median of 38.85 times, placing Aier Eye Hospital at the 25th position in the industry ranking [1] Group 2 - As of the first quarter of 2025, 107 institutions hold shares in Aier Eye Hospital, including 105 funds, with a total shareholding of 416,294.56 million shares valued at 552.84 billion yuan [1] - The company's main business includes diagnosis and surgical services for various eye diseases, with key products being refractive projects, cataract projects, anterior segment projects, posterior segment projects, and optometry services [1] - The latest financial results for the first quarter of 2025 show that the company achieved a revenue of 60.26 billion yuan, a year-on-year increase of 15.97%, and a net profit of 10.50 billion yuan, up 16.71%, with a gross profit margin of 48.02% [1]